Patent 12024484 was granted and assigned to Verve Therapeutics on July, 2024 by the United States Patent and Trademark Office.
The present disclosure relates to PEG-lipids, cationic and/or ionizable lipids and nucleic acid-lipid particle compositions comprising the same. The present disclosure also relates to methods of making, using and delivering the described lipids and lipid-containing particles.